

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gamma-aminobutyric acid transport (GO:0015812) | 6.30547844 |
| 2 | neurofilament cytoskeleton organization (GO:0060052) | 6.17470727 |
| 3 | response to dietary excess (GO:0002021) | 5.39837584 |
| 4 | neuromuscular process controlling posture (GO:0050884) | 4.71833733 |
| 5 | glycoprotein biosynthetic process (GO:0009101) | 4.57138769 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.42608012 |
| 7 | lung-associated mesenchyme development (GO:0060484) | 4.27127051 |
| 8 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.26123533 |
| 9 | endothelial cell chemotaxis (GO:0035767) | 4.15004170 |
| 10 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.12424515 |
| 11 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 4.08779245 |
| 12 | proline transport (GO:0015824) | 4.02564246 |
| 13 | positive regulation of action potential (GO:0045760) | 4.02064252 |
| 14 | positive regulation of synapse maturation (GO:0090129) | 4.02051695 |
| 15 | lipid translocation (GO:0034204) | 4.00393789 |
| 16 | phospholipid translocation (GO:0045332) | 4.00393789 |
| 17 | membrane tubulation (GO:0097320) | 3.92055891 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 3.89883133 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.84218858 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 3.84218858 |
| 21 | lysine metabolic process (GO:0006553) | 3.83520272 |
| 22 | lysine catabolic process (GO:0006554) | 3.83520272 |
| 23 | sex determination (GO:0007530) | 3.81605400 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.79475081 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.79475081 |
| 26 | neuronal action potential (GO:0019228) | 3.77313237 |
| 27 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.74784721 |
| 28 | regulation of energy homeostasis (GO:2000505) | 3.71466639 |
| 29 | regulation of cholesterol homeostasis (GO:2000188) | 3.61494114 |
| 30 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.60890385 |
| 31 | axon extension involved in axon guidance (GO:0048846) | 3.60890385 |
| 32 | regulation of timing of cell differentiation (GO:0048505) | 3.58878467 |
| 33 | positive regulation of protein kinase C signaling (GO:0090037) | 3.56618127 |
| 34 | negative regulation of axon extension (GO:0030517) | 3.56191454 |
| 35 | male sex determination (GO:0030238) | 3.54508246 |
| 36 | semaphorin-plexin signaling pathway (GO:0071526) | 3.49701099 |
| 37 | establishment of mitochondrion localization (GO:0051654) | 3.48075552 |
| 38 | synaptic vesicle exocytosis (GO:0016079) | 3.46906958 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.46524157 |
| 40 | mitochondrion transport along microtubule (GO:0047497) | 3.45474199 |
| 41 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.45474199 |
| 42 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.44955899 |
| 43 | RNA destabilization (GO:0050779) | 3.40696060 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.40605309 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.33976137 |
| 46 | regulation of synapse maturation (GO:0090128) | 3.30413521 |
| 47 | membrane depolarization during action potential (GO:0086010) | 3.29957527 |
| 48 | embryonic eye morphogenesis (GO:0048048) | 3.27890632 |
| 49 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.27164577 |
| 50 | synaptic vesicle maturation (GO:0016188) | 3.24598796 |
| 51 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.22719277 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.18770602 |
| 53 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.18765897 |
| 54 | response to auditory stimulus (GO:0010996) | 3.18704623 |
| 55 | glutamate metabolic process (GO:0006536) | 3.18122207 |
| 56 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16727699 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.16657681 |
| 58 | aromatic amino acid family catabolic process (GO:0009074) | 3.14896938 |
| 59 | cysteine metabolic process (GO:0006534) | 3.11282028 |
| 60 | aspartate family amino acid catabolic process (GO:0009068) | 3.07664882 |
| 61 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.05469144 |
| 62 | regulation of monocyte differentiation (GO:0045655) | 3.05097476 |
| 63 | regulation of action potential (GO:0098900) | 3.04317683 |
| 64 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.04054155 |
| 65 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.04054155 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.03581549 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.03534428 |
| 68 | urea cycle (GO:0000050) | 3.03464627 |
| 69 | urea metabolic process (GO:0019627) | 3.03464627 |
| 70 | glyoxylate metabolic process (GO:0046487) | 3.03154189 |
| 71 | sodium ion export (GO:0071436) | 3.03086642 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.02976736 |
| 73 | negative regulation of axon guidance (GO:1902668) | 3.01362373 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.99319914 |
| 75 | negative regulation of fibrinolysis (GO:0051918) | 2.98768702 |
| 76 | virion attachment to host cell (GO:0019062) | 2.98301432 |
| 77 | adhesion of symbiont to host cell (GO:0044650) | 2.98301432 |
| 78 | neurotransmitter secretion (GO:0007269) | 2.97901441 |
| 79 | bile acid biosynthetic process (GO:0006699) | 2.97375467 |
| 80 | locomotory exploration behavior (GO:0035641) | 2.95930611 |
| 81 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.93773291 |
| 82 | interferon-gamma secretion (GO:0072643) | 2.92744978 |
| 83 | high-density lipoprotein particle remodeling (GO:0034375) | 2.88203617 |
| 84 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.86446815 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85736476 |
| 86 | regulation of development, heterochronic (GO:0040034) | 2.85604720 |
| 87 | behavioral response to pain (GO:0048266) | 2.84248270 |
| 88 | cellular response to ATP (GO:0071318) | 2.84216228 |
| 89 | cellular ketone body metabolic process (GO:0046950) | 2.83647175 |
| 90 | fatty acid transmembrane transport (GO:1902001) | 2.83512678 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 2.82292516 |
| 92 | negative regulation of sterol transport (GO:0032372) | 2.82292516 |
| 93 | adhesion of symbiont to host (GO:0044406) | 2.82007227 |
| 94 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.81382799 |
| 95 | cellular response to electrical stimulus (GO:0071257) | 2.80966289 |
| 96 | carnitine shuttle (GO:0006853) | 2.80649630 |
| 97 | cochlea development (GO:0090102) | 2.79046937 |
| 98 | calcium ion import (GO:0070509) | 2.78718856 |
| 99 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.78199422 |
| 100 | protein carboxylation (GO:0018214) | 2.78199422 |
| 101 | complement activation, alternative pathway (GO:0006957) | 2.78099380 |
| 102 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78049332 |
| 103 | negative regulation of organelle assembly (GO:1902116) | 2.77978665 |
| 104 | regulation of triglyceride catabolic process (GO:0010896) | 2.76847013 |
| 105 | activation of protein kinase A activity (GO:0034199) | 2.76479420 |
| 106 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.75763969 |
| 107 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75039638 |
| 108 | regulation of axon guidance (GO:1902667) | 2.74541596 |
| 109 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.73410015 |
| 110 | macroautophagy (GO:0016236) | 2.73265493 |
| 111 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.72802372 |
| 112 | nitrogen cycle metabolic process (GO:0071941) | 2.72440688 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 2.69048524 |
| 114 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.68060333 |
| 115 | reverse cholesterol transport (GO:0043691) | 2.67710137 |
| 116 | glycerophospholipid catabolic process (GO:0046475) | 2.67447823 |
| 117 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.65972277 |
| 118 | homocysteine metabolic process (GO:0050667) | 2.65038712 |
| 119 | regulation of fatty acid oxidation (GO:0046320) | 2.64669339 |
| 120 | cell communication by electrical coupling (GO:0010644) | 2.64621050 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 2.63947250 |
| 122 | amino-acid betaine metabolic process (GO:0006577) | 2.63306701 |
| 123 | negative regulation of cell size (GO:0045792) | 2.62956670 |
| 124 | bile acid metabolic process (GO:0008206) | 2.62854591 |
| 125 | layer formation in cerebral cortex (GO:0021819) | 2.62437526 |
| 126 | serine family amino acid catabolic process (GO:0009071) | 2.62221141 |
| 127 | synaptic transmission, glutamatergic (GO:0035249) | 2.61398187 |
| 128 | O-glycan processing (GO:0016266) | 2.60691931 |
| 129 | regulation of protein activation cascade (GO:2000257) | 2.60494666 |
| 130 | positive regulation of fatty acid oxidation (GO:0046321) | 2.60429988 |
| 131 | indole-containing compound catabolic process (GO:0042436) | 2.59541225 |
| 132 | indolalkylamine catabolic process (GO:0046218) | 2.59541225 |
| 133 | tryptophan catabolic process (GO:0006569) | 2.59541225 |
| 134 | 4-hydroxyproline metabolic process (GO:0019471) | 2.58532622 |
| 135 | regulation of fibrinolysis (GO:0051917) | 2.57669207 |
| 136 | dicarboxylic acid catabolic process (GO:0043649) | 2.56759984 |
| 137 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.56032312 |
| 138 | biotin metabolic process (GO:0006768) | 2.55964574 |
| 139 | tricarboxylic acid metabolic process (GO:0072350) | 2.55835638 |
| 140 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.54845829 |
| 141 | phospholipid homeostasis (GO:0055091) | 2.54381603 |
| 142 | acetyl-CoA metabolic process (GO:0006084) | 2.53698837 |
| 143 | alpha-amino acid catabolic process (GO:1901606) | 2.53615229 |
| 144 | plasma lipoprotein particle clearance (GO:0034381) | 2.53505442 |
| 145 | regulation of synapse structural plasticity (GO:0051823) | 2.53349321 |
| 146 | drug catabolic process (GO:0042737) | 2.52682372 |
| 147 | bone morphogenesis (GO:0060349) | 2.52324570 |
| 148 | ketone body metabolic process (GO:1902224) | 2.52141197 |
| 149 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.51287525 |
| 150 | alanine transport (GO:0032328) | 2.51103386 |
| 151 | activation of MAPKKK activity (GO:0000185) | 2.50855334 |
| 152 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.50715950 |
| 153 | cellular amino acid catabolic process (GO:0009063) | 2.50636666 |
| 154 | plasma membrane repair (GO:0001778) | 2.50302917 |
| 155 | acylglycerol homeostasis (GO:0055090) | 2.50249326 |
| 156 | triglyceride homeostasis (GO:0070328) | 2.50249326 |
| 157 | regulation of cholesterol metabolic process (GO:0090181) | 2.50076167 |
| 158 | regulation of ARF protein signal transduction (GO:0032012) | 2.49636293 |
| 159 | urinary tract smooth muscle contraction (GO:0014848) | 2.48974233 |
| 160 | oligodendrocyte differentiation (GO:0048709) | 2.48719536 |
| 161 | cell communication involved in cardiac conduction (GO:0086065) | 2.47583202 |
| 162 | fatty acid beta-oxidation (GO:0006635) | 2.46680173 |
| 163 | regulation of complement activation (GO:0030449) | 2.45256152 |
| 164 | fatty acid homeostasis (GO:0055089) | 2.44762262 |
| 165 | regulation of mesenchymal cell proliferation (GO:0010464) | 2.43599413 |
| 166 | mannose metabolic process (GO:0006013) | 2.41956362 |
| 167 | diaphragm development (GO:0060539) | 2.41880297 |
| 168 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.41196215 |
| 169 | axonal fasciculation (GO:0007413) | 2.41140872 |
| 170 | post-anal tail morphogenesis (GO:0036342) | 2.41079171 |
| 171 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.41000614 |
| 172 | tryptophan metabolic process (GO:0006568) | 2.40917937 |
| 173 | phospholipid efflux (GO:0033700) | 2.39866418 |
| 174 | valine metabolic process (GO:0006573) | 2.38558318 |
| 175 | protein-lipid complex remodeling (GO:0034368) | 2.38545492 |
| 176 | macromolecular complex remodeling (GO:0034367) | 2.38545492 |
| 177 | plasma lipoprotein particle remodeling (GO:0034369) | 2.38545492 |
| 178 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.38340609 |
| 179 | regulation of protein kinase C signaling (GO:0090036) | 2.37633674 |
| 180 | dopamine receptor signaling pathway (GO:0007212) | 2.37143684 |
| 181 | acylglycerol catabolic process (GO:0046464) | 2.35957536 |
| 182 | neutral lipid catabolic process (GO:0046461) | 2.35957536 |
| 183 | cerebellar Purkinje cell layer development (GO:0021680) | 2.35199139 |
| 184 | negative regulation of lipid transport (GO:0032369) | 2.34940701 |
| 185 | ethanol oxidation (GO:0006069) | 2.34759062 |
| 186 | regulation of lipid catabolic process (GO:0050994) | 2.34365740 |
| 187 | glutamate secretion (GO:0014047) | 2.33219831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.06373563 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76335097 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.33659788 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.24096155 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.13391837 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.05256444 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.54097201 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.51290899 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47994711 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.25822253 |
| 11 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.25081252 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24890289 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09049321 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.98343957 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97212843 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97139155 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94465400 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88621821 |
| 19 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85950402 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.85353673 |
| 21 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.83352800 |
| 22 | KDM2B_26808549_Chip-Seq_K562_Human | 1.82538155 |
| 23 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.82131074 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.80324958 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78379385 |
| 26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76017887 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.73980905 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.73969532 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73123387 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64759572 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.62045157 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.61751055 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.60568317 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.60267576 |
| 35 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.58669081 |
| 36 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58254166 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57482251 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.54536251 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52573394 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50040856 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.47914888 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47855764 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47851083 |
| 44 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42775656 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40442841 |
| 46 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38590879 |
| 47 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35545340 |
| 48 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34159957 |
| 49 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34003283 |
| 50 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33920483 |
| 51 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.30561596 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30295471 |
| 53 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.29558789 |
| 54 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28303777 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27207258 |
| 56 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.25786807 |
| 57 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25067190 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.24334116 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24201114 |
| 60 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.23598404 |
| 61 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.23213615 |
| 62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.23194796 |
| 63 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22532537 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.22528008 |
| 65 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.22528008 |
| 66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.21406272 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20736979 |
| 68 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20641598 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20623724 |
| 70 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20460196 |
| 71 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.19979968 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19886877 |
| 73 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.19525128 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.18742852 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16967152 |
| 76 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.16813626 |
| 77 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.16813626 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.16563402 |
| 79 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15435718 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15147859 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14819795 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13880694 |
| 83 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.13610672 |
| 84 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12668896 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11692960 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.10889813 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10172080 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09260161 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.09133774 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09107321 |
| 91 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09070611 |
| 92 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08646670 |
| 93 | P68_20966046_ChIP-Seq_HELA_Human | 1.08394791 |
| 94 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08270536 |
| 95 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08253282 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08095174 |
| 97 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07206561 |
| 98 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06999831 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06812136 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06516148 |
| 101 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05725896 |
| 102 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05376750 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04926648 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04918789 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03498877 |
| 106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.03149760 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02923920 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02015726 |
| 109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01724097 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01687148 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00993101 |
| 112 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.00310975 |
| 113 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00228001 |
| 114 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99435802 |
| 115 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.99288089 |
| 116 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.98435894 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97158598 |
| 118 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97054588 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96684953 |
| 120 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96207082 |
| 121 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94299934 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91613283 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91419550 |
| 124 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.91327658 |
| 125 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91071591 |
| 126 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90911044 |
| 127 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.90553147 |
| 128 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88001690 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87804003 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.87210289 |
| 131 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.86662882 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86513733 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.86407528 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85775296 |
| 135 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85561407 |
| 136 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84156982 |
| 137 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.84110428 |
| 138 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84100812 |
| 139 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83970636 |
| 140 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83135770 |
| 141 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.82666007 |
| 142 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82361828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 9.17860715 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.78940086 |
| 3 | MP0005360_urolithiasis | 4.45061952 |
| 4 | MP0005365_abnormal_bile_salt | 3.77927505 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.77913797 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.65448993 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.15593651 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.03792004 |
| 9 | MP0003252_abnormal_bile_duct | 2.78198478 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.60774000 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.52034734 |
| 12 | MP0005083_abnormal_biliary_tract | 2.46536258 |
| 13 | MP0009840_abnormal_foam_cell | 2.40106689 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.36706152 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.29662963 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.22841406 |
| 17 | MP0002249_abnormal_larynx_morphology | 2.21949941 |
| 18 | MP0003880_abnormal_central_pattern | 2.17368279 |
| 19 | MP0004130_abnormal_muscle_cell | 2.16362590 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.13682765 |
| 21 | MP0008961_abnormal_basal_metabolism | 2.09642258 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.08059398 |
| 23 | MP0000462_abnormal_digestive_system | 1.97569424 |
| 24 | MP0003283_abnormal_digestive_organ | 1.96818683 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.94179030 |
| 26 | MP0003195_calcinosis | 1.89842094 |
| 27 | MP0002822_catalepsy | 1.89044604 |
| 28 | MP0003329_amyloid_beta_deposits | 1.84410770 |
| 29 | MP0009046_muscle_twitch | 1.82815823 |
| 30 | MP0005332_abnormal_amino_acid | 1.76240631 |
| 31 | MP0002272_abnormal_nervous_system | 1.74851268 |
| 32 | MP0000751_myopathy | 1.73188207 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.69427122 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.69223628 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.68974565 |
| 36 | MP0005595_abnormal_vascular_smooth | 1.60572676 |
| 37 | MP0004134_abnormal_chest_morphology | 1.60377584 |
| 38 | MP0004858_abnormal_nervous_system | 1.57784733 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.56350538 |
| 40 | MP0005171_absent_coat_pigmentation | 1.52102803 |
| 41 | MP0008995_early_reproductive_senescence | 1.49756745 |
| 42 | MP0003635_abnormal_synaptic_transmissio | 1.49469825 |
| 43 | MP0001970_abnormal_pain_threshold | 1.48607801 |
| 44 | MP0004270_analgesia | 1.48096361 |
| 45 | MP0004043_abnormal_pH_regulation | 1.47457672 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.47023862 |
| 47 | MP0005257_abnormal_intraocular_pressure | 1.42948203 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.42899269 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.42020978 |
| 50 | MP0003123_paternal_imprinting | 1.41357008 |
| 51 | MP0000609_abnormal_liver_physiology | 1.40157301 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.39674195 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.38765933 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.36799150 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.35616056 |
| 56 | MP0000678_abnormal_parathyroid_gland | 1.35567413 |
| 57 | MP0003136_yellow_coat_color | 1.33974762 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.30405111 |
| 59 | MP0001440_abnormal_grooming_behavior | 1.29589121 |
| 60 | MP0000604_amyloidosis | 1.29025268 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.28850927 |
| 62 | MP0001485_abnormal_pinna_reflex | 1.25773576 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 1.24356644 |
| 64 | MP0001486_abnormal_startle_reflex | 1.24272415 |
| 65 | MP0005375_adipose_tissue_phenotype | 1.23401552 |
| 66 | MP0005508_abnormal_skeleton_morphology | 1.22849097 |
| 67 | MP0005670_abnormal_white_adipose | 1.21885001 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.21234790 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 1.20931317 |
| 70 | MP0002269_muscular_atrophy | 1.19971142 |
| 71 | MP0003075_altered_response_to | 1.19805801 |
| 72 | MP0000747_muscle_weakness | 1.17243843 |
| 73 | MP0004036_abnormal_muscle_relaxation | 1.16563256 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 1.16482455 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.16335175 |
| 76 | MP0004087_abnormal_muscle_fiber | 1.15382762 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14106725 |
| 78 | MP0005058_abnormal_lysosome_morphology | 1.13606757 |
| 79 | MP0002932_abnormal_joint_morphology | 1.12347308 |
| 80 | MP0004084_abnormal_cardiac_muscle | 1.11826625 |
| 81 | MP0000049_abnormal_middle_ear | 1.10954629 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 1.10039369 |
| 83 | MP0002063_abnormal_learning/memory/cond | 1.09035722 |
| 84 | MP0005535_abnormal_body_temperature | 1.08449408 |
| 85 | MP0003868_abnormal_feces_composition | 1.08304312 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.07388486 |
| 87 | MP0005330_cardiomyopathy | 1.05512036 |
| 88 | MP0009643_abnormal_urine_homeostasis | 1.04033275 |
| 89 | MP0010030_abnormal_orbit_morphology | 1.01925089 |
| 90 | MP0001299_abnormal_eye_distance/ | 0.98401940 |
| 91 | MP0000569_abnormal_digit_pigmentation | 0.97700958 |
| 92 | MP0004885_abnormal_endolymph | 0.95651198 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.95433704 |
| 94 | MP0000733_abnormal_muscle_development | 0.95413398 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.95258722 |
| 96 | MP0003646_muscle_fatigue | 0.95057780 |
| 97 | MP0002971_abnormal_brown_adipose | 0.92309598 |
| 98 | MP0005187_abnormal_penis_morphology | 0.91922981 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.91834679 |
| 100 | MP0003045_fibrosis | 0.91150986 |
| 101 | MP0004381_abnormal_hair_follicle | 0.89765073 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.89552099 |
| 103 | MP0003633_abnormal_nervous_system | 0.85511135 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.85250022 |
| 105 | MP0009745_abnormal_behavioral_response | 0.85119738 |
| 106 | MP0004233_abnormal_muscle_weight | 0.84708286 |
| 107 | MP0003690_abnormal_glial_cell | 0.84054850 |
| 108 | MP0002064_seizures | 0.83755698 |
| 109 | MP0005174_abnormal_tail_pigmentation | 0.83664921 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.83478482 |
| 111 | MP0005448_abnormal_energy_balance | 0.83145722 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.82968627 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.82677658 |
| 114 | MP0001944_abnormal_pancreas_morphology | 0.82287530 |
| 115 | MP0001756_abnormal_urination | 0.82060813 |
| 116 | MP0003879_abnormal_hair_cell | 0.81903008 |
| 117 | MP0008874_decreased_physiological_sensi | 0.81679152 |
| 118 | MP0002116_abnormal_craniofacial_bone | 0.81663251 |
| 119 | MP0004924_abnormal_behavior | 0.81210051 |
| 120 | MP0005386_behavior/neurological_phenoty | 0.81210051 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.81071250 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.80184865 |
| 123 | MP0004215_abnormal_myocardial_fiber | 0.79749429 |
| 124 | MP0001664_abnormal_digestion | 0.78806261 |
| 125 | MP0005409_darkened_coat_color | 0.78054915 |
| 126 | MP0004085_abnormal_heartbeat | 0.77783773 |
| 127 | MP0000026_abnormal_inner_ear | 0.77163944 |
| 128 | MP0002184_abnormal_innervation | 0.75541817 |
| 129 | MP0005620_abnormal_muscle_contractility | 0.75130516 |
| 130 | MP0002066_abnormal_motor_capabilities/c | 0.75044363 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.74825981 |
| 132 | MP0008569_lethality_at_weaning | 0.74344046 |
| 133 | MP0001849_ear_inflammation | 0.74233182 |
| 134 | MP0005334_abnormal_fat_pad | 0.74156361 |
| 135 | MP0001963_abnormal_hearing_physiology | 0.74016577 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.72594032 |
| 137 | MP0003953_abnormal_hormone_level | 0.72435325 |
| 138 | MP0000749_muscle_degeneration | 0.72404480 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.71305948 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.71271426 |
| 141 | MP0003755_abnormal_palate_morphology | 0.68525232 |
| 142 | MP0009931_abnormal_skin_appearance | 0.67939373 |
| 143 | MP0003172_abnormal_lysosome_physiology | 0.67889843 |
| 144 | MP0004811_abnormal_neuron_physiology | 0.67841181 |
| 145 | MP0010368_abnormal_lymphatic_system | 0.67742432 |
| 146 | MP0002098_abnormal_vibrissa_morphology | 0.67238468 |
| 147 | MP0000759_abnormal_skeletal_muscle | 0.66444454 |
| 148 | MP0006138_congestive_heart_failure | 0.65863441 |
| 149 | MP0004510_myositis | 0.65851840 |
| 150 | MP0003137_abnormal_impulse_conducting | 0.65609781 |
| 151 | MP0003115_abnormal_respiratory_system | 0.65341442 |
| 152 | MP0003634_abnormal_glial_cell | 0.64769421 |
| 153 | MP0000428_abnormal_craniofacial_morphol | 0.63664749 |
| 154 | MP0004133_heterotaxia | 0.63105242 |
| 155 | MP0000383_abnormal_hair_follicle | 0.63079032 |
| 156 | MP0002069_abnormal_eating/drinking_beha | 0.62589606 |
| 157 | MP0005381_digestive/alimentary_phenotyp | 0.62267337 |
| 158 | MP0004264_abnormal_extraembryonic_tissu | 0.61537381 |
| 159 | MP0000579_abnormal_nail_morphology | 0.61276933 |
| 160 | MP0002972_abnormal_cardiac_muscle | 0.60754520 |
| 161 | MP0000598_abnormal_liver_morphology | 0.60376292 |
| 162 | MP0005166_decreased_susceptibility_to | 0.60243663 |
| 163 | MP0002796_impaired_skin_barrier | 0.60151226 |
| 164 | MP0001958_emphysema | 0.58977686 |
| 165 | MP0000762_abnormal_tongue_morphology | 0.58190085 |
| 166 | MP0001340_abnormal_eyelid_morphology | 0.57935607 |
| 167 | MP0002111_abnormal_tail_morphology | 0.56578560 |
| 168 | MP0000163_abnormal_cartilage_morphology | 0.56155975 |
| 169 | MP0000778_abnormal_nervous_system | 0.55713130 |
| 170 | MP0000470_abnormal_stomach_morphology | 0.55623496 |
| 171 | MP0003787_abnormal_imprinting | 0.54625421 |
| 172 | MP0000538_abnormal_urinary_bladder | 0.53637393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bradycardia (HP:0001662) | 6.96575835 |
| 2 | Synostosis involving the elbow (HP:0003938) | 5.04918583 |
| 3 | Humeroradial synostosis (HP:0003041) | 5.04918583 |
| 4 | Atonic seizures (HP:0010819) | 4.30801415 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.25321248 |
| 6 | Atrial fibrillation (HP:0005110) | 3.67496860 |
| 7 | Xanthomatosis (HP:0000991) | 3.58876671 |
| 8 | Ulnar claw (HP:0001178) | 3.50254219 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 3.42685829 |
| 10 | Ketoacidosis (HP:0001993) | 3.42329350 |
| 11 | Ketosis (HP:0001946) | 3.41212132 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.36516370 |
| 13 | Supraventricular tachycardia (HP:0004755) | 3.34994515 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.30124431 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 3.25532696 |
| 16 | Difficulty climbing stairs (HP:0003551) | 3.24168867 |
| 17 | Abnormality of the aortic arch (HP:0012303) | 3.23182682 |
| 18 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.12597002 |
| 19 | Abnormality of the lower motor neuron (HP:0002366) | 3.08867098 |
| 20 | Hypoglycemic coma (HP:0001325) | 3.05599160 |
| 21 | Febrile seizures (HP:0002373) | 3.04574501 |
| 22 | Absence seizures (HP:0002121) | 3.04420204 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.03168481 |
| 24 | Gout (HP:0001997) | 2.87964658 |
| 25 | Amblyopia (HP:0000646) | 2.85575866 |
| 26 | Complement deficiency (HP:0004431) | 2.82807954 |
| 27 | Epileptic encephalopathy (HP:0200134) | 2.79319388 |
| 28 | Neoplasm of the heart (HP:0100544) | 2.78569083 |
| 29 | Obstructive sleep apnea (HP:0002870) | 2.78162217 |
| 30 | Flat capital femoral epiphysis (HP:0003370) | 2.77261197 |
| 31 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.76459048 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 2.71312659 |
| 33 | Inability to walk (HP:0002540) | 2.70195680 |
| 34 | J-shaped sella turcica (HP:0002680) | 2.69883333 |
| 35 | Bundle branch block (HP:0011710) | 2.66898031 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.63285357 |
| 37 | Abnormality of the Achilles tendon (HP:0005109) | 2.60559689 |
| 38 | Hyperammonemia (HP:0001987) | 2.59674506 |
| 39 | Focal seizures (HP:0007359) | 2.59627507 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.58877172 |
| 41 | Akinesia (HP:0002304) | 2.57642817 |
| 42 | Myoglobinuria (HP:0002913) | 2.51397580 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.50653473 |
| 44 | Gaze-evoked nystagmus (HP:0000640) | 2.48131423 |
| 45 | Menstrual irregularities (HP:0000858) | 2.47875506 |
| 46 | Epidermoid cyst (HP:0200040) | 2.46537207 |
| 47 | Hyperglycinuria (HP:0003108) | 2.44832321 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.44829270 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.44829270 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.44829270 |
| 51 | Ventricular fibrillation (HP:0001663) | 2.43368495 |
| 52 | Truncal ataxia (HP:0002078) | 2.43365866 |
| 53 | Stridor (HP:0010307) | 2.41326189 |
| 54 | Hypoventilation (HP:0002791) | 2.40661749 |
| 55 | Morphological abnormality of the middle ear (HP:0008609) | 2.40109566 |
| 56 | Turricephaly (HP:0000262) | 2.39971940 |
| 57 | Hypothermia (HP:0002045) | 2.39693522 |
| 58 | Visceral angiomatosis (HP:0100761) | 2.39670277 |
| 59 | Thin bony cortex (HP:0002753) | 2.39035831 |
| 60 | Annular pancreas (HP:0001734) | 2.36930304 |
| 61 | Myokymia (HP:0002411) | 2.35157582 |
| 62 | Upper limb amyotrophy (HP:0009129) | 2.32848736 |
| 63 | Distal upper limb amyotrophy (HP:0007149) | 2.32848736 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.32806490 |
| 65 | Achilles tendon contracture (HP:0001771) | 2.32690875 |
| 66 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.32370769 |
| 67 | Skin nodule (HP:0200036) | 2.32279154 |
| 68 | Sudden death (HP:0001699) | 2.31737775 |
| 69 | Late onset (HP:0003584) | 2.31302208 |
| 70 | Spinal muscular atrophy (HP:0007269) | 2.30683224 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.28786388 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.27719908 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.27719908 |
| 74 | Abnormality of the common coagulation pathway (HP:0010990) | 2.26355853 |
| 75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.26118924 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.26118924 |
| 77 | Hypobetalipoproteinemia (HP:0003563) | 2.25971364 |
| 78 | Hypolipoproteinemia (HP:0010981) | 2.25351147 |
| 79 | Dysmetria (HP:0001310) | 2.25339995 |
| 80 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.24279487 |
| 81 | Focal motor seizures (HP:0011153) | 2.23796624 |
| 82 | Dysmetric saccades (HP:0000641) | 2.23618677 |
| 83 | Visual hallucinations (HP:0002367) | 2.23184583 |
| 84 | Lymphangioma (HP:0100764) | 2.23165306 |
| 85 | Difficulty running (HP:0009046) | 2.21703663 |
| 86 | Hyporeflexia of lower limbs (HP:0002600) | 2.20545672 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 2.19984386 |
| 88 | Mesangial abnormality (HP:0001966) | 2.19169056 |
| 89 | Cerebral aneurysm (HP:0004944) | 2.18326473 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.17611653 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.16890791 |
| 92 | Hemangiomatosis (HP:0007461) | 2.16837596 |
| 93 | Broad face (HP:0000283) | 2.16177949 |
| 94 | Hyperglycinemia (HP:0002154) | 2.14200563 |
| 95 | Atrioventricular block (HP:0001678) | 2.12926033 |
| 96 | Congenital stationary night blindness (HP:0007642) | 2.10508222 |
| 97 | Cholelithiasis (HP:0001081) | 2.10034153 |
| 98 | Insomnia (HP:0100785) | 2.09777549 |
| 99 | Neonatal onset (HP:0003623) | 2.09096516 |
| 100 | Hyperglycemia (HP:0003074) | 2.07961269 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 2.06824232 |
| 102 | Abnormality of purine metabolism (HP:0004352) | 2.05830085 |
| 103 | Self-mutilation (HP:0000742) | 2.05101122 |
| 104 | Global brain atrophy (HP:0002283) | 2.05092585 |
| 105 | Severe muscular hypotonia (HP:0006829) | 2.03936434 |
| 106 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03078092 |
| 107 | Cerebral inclusion bodies (HP:0100314) | 2.03039067 |
| 108 | Abnormality of the intrinsic pathway (HP:0010989) | 2.02985240 |
| 109 | Hand muscle atrophy (HP:0009130) | 2.02805251 |
| 110 | Long toe (HP:0010511) | 2.02514248 |
| 111 | Abnormality of the humeroradial joint (HP:0100744) | 2.01499146 |
| 112 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00643627 |
| 113 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00643627 |
| 114 | Aplasia involving bones of the extremities (HP:0009825) | 2.00643627 |
| 115 | Heart block (HP:0012722) | 1.99213267 |
| 116 | Impaired social interactions (HP:0000735) | 1.99001934 |
| 117 | Abnormal social behavior (HP:0012433) | 1.99001934 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98829392 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 1.98282089 |
| 120 | Dialeptic seizures (HP:0011146) | 1.98182716 |
| 121 | Ulnar bowing (HP:0003031) | 1.98049749 |
| 122 | Abnormality of complement system (HP:0005339) | 1.97545364 |
| 123 | Status epilepticus (HP:0002133) | 1.97220564 |
| 124 | Polycythemia (HP:0001901) | 1.96681334 |
| 125 | Hyperacusis (HP:0010780) | 1.96670510 |
| 126 | Large for gestational age (HP:0001520) | 1.95915055 |
| 127 | Back pain (HP:0003418) | 1.95307853 |
| 128 | Concave nail (HP:0001598) | 1.95100975 |
| 129 | Abnormality of the sella turcica (HP:0002679) | 1.94678892 |
| 130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.94648970 |
| 131 | Torticollis (HP:0000473) | 1.94044592 |
| 132 | Hypopigmentation of the fundus (HP:0007894) | 1.92859676 |
| 133 | Resting tremor (HP:0002322) | 1.92780336 |
| 134 | Aortic regurgitation (HP:0001659) | 1.92300053 |
| 135 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.91828546 |
| 136 | Exercise-induced muscle cramps (HP:0003710) | 1.91281711 |
| 137 | Palpebral edema (HP:0100540) | 1.90516102 |
| 138 | Joint stiffness (HP:0001387) | 1.90474016 |
| 139 | Action tremor (HP:0002345) | 1.89408808 |
| 140 | Abnormal atrioventricular conduction (HP:0005150) | 1.89385849 |
| 141 | Abnormal hair laboratory examination (HP:0003328) | 1.88938615 |
| 142 | Prolonged partial thromboplastin time (HP:0003645) | 1.87978853 |
| 143 | Difficulty walking (HP:0002355) | 1.85901287 |
| 144 | Postural instability (HP:0002172) | 1.85703928 |
| 145 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.85703117 |
| 146 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.85703117 |
| 147 | Supranuclear gaze palsy (HP:0000605) | 1.85388995 |
| 148 | Nuclear cataract (HP:0100018) | 1.85257376 |
| 149 | Depression (HP:0000716) | 1.83974385 |
| 150 | Delayed CNS myelination (HP:0002188) | 1.83658554 |
| 151 | Hemiplegia (HP:0002301) | 1.83429653 |
| 152 | Increased connective tissue (HP:0009025) | 1.82385329 |
| 153 | Aneurysm (HP:0002617) | 1.82328121 |
| 154 | Macroorchidism (HP:0000053) | 1.82069719 |
| 155 | Enlarged penis (HP:0000040) | 1.80673267 |
| 156 | Hypercholesterolemia (HP:0003124) | 1.80362825 |
| 157 | Sensorimotor neuropathy (HP:0007141) | 1.78130481 |
| 158 | Hamartoma of the eye (HP:0010568) | 1.78105333 |
| 159 | Septo-optic dysplasia (HP:0100842) | 1.77418468 |
| 160 | Reticulocytosis (HP:0001923) | 1.76961693 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76884507 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76884507 |
| 163 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76884507 |
| 164 | Malnutrition (HP:0004395) | 1.76441379 |
| 165 | Spastic diplegia (HP:0001264) | 1.74642464 |
| 166 | Bulbous nose (HP:0000414) | 1.74401142 |
| 167 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73298460 |
| 168 | Synostosis involving bones of the hand (HP:0004278) | 1.73224334 |
| 169 | Shallow orbits (HP:0000586) | 1.72348228 |
| 170 | Ventricular arrhythmia (HP:0004308) | 1.70801579 |
| 171 | Broad metatarsal (HP:0001783) | 1.70348516 |
| 172 | Renal cell carcinoma (HP:0005584) | 1.69868725 |
| 173 | Myocardial infarction (HP:0001658) | 1.69782041 |
| 174 | Elfin facies (HP:0004428) | 1.69534984 |
| 175 | EMG: neuropathic changes (HP:0003445) | 1.69420402 |
| 176 | Intention tremor (HP:0002080) | 1.68962701 |
| 177 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.68908191 |
| 178 | Hyperbilirubinemia (HP:0002904) | 1.68457797 |
| 179 | Mucopolysacchariduria (HP:0008155) | 1.67090227 |
| 180 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67090227 |
| 181 | Anosmia (HP:0000458) | 1.66999545 |
| 182 | Cervical subluxation (HP:0003308) | 1.66733958 |
| 183 | Pointed chin (HP:0000307) | 1.65727479 |
| 184 | Abnormal eating behavior (HP:0100738) | 1.65299383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.41078170 |
| 2 | TNK2 | 3.13946164 |
| 3 | PKN2 | 3.01360597 |
| 4 | ERN1 | 2.62181322 |
| 5 | PRKD3 | 2.56727873 |
| 6 | RIPK1 | 2.43978068 |
| 7 | MAP3K9 | 2.33989223 |
| 8 | SMG1 | 2.27794222 |
| 9 | DAPK2 | 2.17016296 |
| 10 | EPHA2 | 2.14883705 |
| 11 | SIK1 | 2.14409552 |
| 12 | KSR2 | 2.06808627 |
| 13 | BCKDK | 1.89058924 |
| 14 | EPHA4 | 1.75070155 |
| 15 | IRAK3 | 1.74887996 |
| 16 | CAMKK1 | 1.73260163 |
| 17 | TAOK1 | 1.70268766 |
| 18 | PDGFRA | 1.69189760 |
| 19 | PAK6 | 1.67778579 |
| 20 | PTK6 | 1.65965476 |
| 21 | ICK | 1.58864131 |
| 22 | NTRK3 | 1.54790970 |
| 23 | TTN | 1.54152594 |
| 24 | MAPK15 | 1.53251694 |
| 25 | LMTK2 | 1.46203503 |
| 26 | MAP3K2 | 1.46057009 |
| 27 | STK38 | 1.42193785 |
| 28 | CAMK2G | 1.39771964 |
| 29 | MAP3K10 | 1.37600338 |
| 30 | MAP2K4 | 1.37587012 |
| 31 | NTRK1 | 1.36347687 |
| 32 | TYRO3 | 1.33942782 |
| 33 | FGFR4 | 1.32882506 |
| 34 | INSRR | 1.32392797 |
| 35 | EEF2K | 1.31775316 |
| 36 | RET | 1.31515375 |
| 37 | MAP3K7 | 1.31498523 |
| 38 | MUSK | 1.24539994 |
| 39 | PRKCH | 1.23996763 |
| 40 | PHKG1 | 1.20409378 |
| 41 | PHKG2 | 1.20409378 |
| 42 | MAP3K4 | 1.12018344 |
| 43 | NEK1 | 1.11439498 |
| 44 | MAP4K1 | 1.11284319 |
| 45 | MAP3K1 | 1.08953252 |
| 46 | CAMK1G | 1.07060116 |
| 47 | RPS6KA6 | 1.06557763 |
| 48 | BMX | 1.04640391 |
| 49 | LATS2 | 1.03119161 |
| 50 | ALK | 1.02173928 |
| 51 | LATS1 | 0.98822703 |
| 52 | RPS6KL1 | 0.98119307 |
| 53 | RPS6KC1 | 0.98119307 |
| 54 | PDK3 | 0.97096127 |
| 55 | PDK4 | 0.97096127 |
| 56 | SIK2 | 0.96864745 |
| 57 | MINK1 | 0.96554071 |
| 58 | TAOK3 | 0.96344577 |
| 59 | DMPK | 0.92895524 |
| 60 | SCYL2 | 0.92430781 |
| 61 | PAK3 | 0.91959895 |
| 62 | PTK2 | 0.91253462 |
| 63 | PINK1 | 0.91155056 |
| 64 | PDPK1 | 0.89688556 |
| 65 | CAMK2B | 0.89492803 |
| 66 | PRPF4B | 0.87117108 |
| 67 | SGK3 | 0.85488682 |
| 68 | CAMK1D | 0.85401912 |
| 69 | DDR2 | 0.84512994 |
| 70 | MAP2K6 | 0.84065900 |
| 71 | MARK1 | 0.83167060 |
| 72 | PDK1 | 0.77062976 |
| 73 | CDC42BPA | 0.75710814 |
| 74 | STK11 | 0.74279842 |
| 75 | PRKCG | 0.74198773 |
| 76 | TESK1 | 0.72664436 |
| 77 | MTOR | 0.72291096 |
| 78 | PRKAA1 | 0.72113247 |
| 79 | MARK2 | 0.71993013 |
| 80 | CDK5 | 0.71895104 |
| 81 | KSR1 | 0.71412889 |
| 82 | JAK2 | 0.71209594 |
| 83 | FER | 0.71070360 |
| 84 | PRKD1 | 0.70418818 |
| 85 | WNK4 | 0.66556232 |
| 86 | NTRK2 | 0.65724695 |
| 87 | DYRK1B | 0.65277518 |
| 88 | ABL2 | 0.63857137 |
| 89 | EPHB1 | 0.63623356 |
| 90 | FGFR2 | 0.62675822 |
| 91 | MAP3K11 | 0.60711706 |
| 92 | MAP2K1 | 0.60176559 |
| 93 | UHMK1 | 0.59856816 |
| 94 | NME1 | 0.59774225 |
| 95 | CAMK4 | 0.57734452 |
| 96 | DAPK1 | 0.56908988 |
| 97 | IRAK2 | 0.55783538 |
| 98 | PRKD2 | 0.55725771 |
| 99 | JAK1 | 0.55273448 |
| 100 | CHUK | 0.55214857 |
| 101 | PDGFRB | 0.55087059 |
| 102 | PRKG2 | 0.53754647 |
| 103 | MAP2K2 | 0.52568174 |
| 104 | PRKCZ | 0.51531944 |
| 105 | WNK1 | 0.50936105 |
| 106 | MST1R | 0.50759185 |
| 107 | ERBB2 | 0.50245454 |
| 108 | MELK | 0.50111789 |
| 109 | MAPK11 | 0.48989733 |
| 110 | DAPK3 | 0.45537117 |
| 111 | MAPK12 | 0.45311381 |
| 112 | RPS6KA2 | 0.45271937 |
| 113 | FRK | 0.45135050 |
| 114 | HIPK2 | 0.44850993 |
| 115 | STK16 | 0.44559429 |
| 116 | PTK2B | 0.44429362 |
| 117 | RPS6KA3 | 0.44280845 |
| 118 | LRRK2 | 0.44138189 |
| 119 | CAMK1 | 0.44080886 |
| 120 | MAPKAPK3 | 0.44023172 |
| 121 | PRKAA2 | 0.43660411 |
| 122 | RPS6KA1 | 0.43361722 |
| 123 | PRKACG | 0.42152598 |
| 124 | MAP3K13 | 0.41139089 |
| 125 | SGK494 | 0.40778446 |
| 126 | SGK223 | 0.40778446 |
| 127 | MAPK8 | 0.40578845 |
| 128 | CSNK1A1 | 0.39527164 |
| 129 | PRKCI | 0.37468315 |
| 130 | CAMK2D | 0.37199868 |
| 131 | MAPKAPK2 | 0.36954323 |
| 132 | MAP3K3 | 0.36919543 |
| 133 | MAPK4 | 0.31764342 |
| 134 | ZAP70 | 0.31644903 |
| 135 | ADRBK2 | 0.30513938 |
| 136 | CDK15 | 0.29382522 |
| 137 | TXK | 0.29104875 |
| 138 | EPHB2 | 0.28407683 |
| 139 | GRK1 | 0.28104152 |
| 140 | SRC | 0.28074592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 4.96569856 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.97397065 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05870996 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.68070937 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56617676 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48673298 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99221622 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95417247 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.92861080 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 1.86244544 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.85283872 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.81827560 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.77761718 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75547709 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75192947 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72300150 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72148525 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.57490504 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57427837 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53648489 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.52328945 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48709597 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.43317138 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43076384 |
| 25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.33048934 |
| 26 | Melanoma_Homo sapiens_hsa05218 | 1.27562261 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25384381 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21981108 |
| 29 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21409068 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20237568 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.14143724 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.13169310 |
| 33 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12022021 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11736598 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.05923639 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 1.02388066 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01450022 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99629298 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 0.99627892 |
| 40 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98785569 |
| 41 | Insulin resistance_Homo sapiens_hsa04931 | 0.98621799 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98243387 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.96633853 |
| 44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96444988 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95739381 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95189356 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94956639 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.93836546 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93584988 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92376136 |
| 51 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.92075232 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91367118 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90321042 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.89913552 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89550170 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88484204 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.88172568 |
| 58 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87814538 |
| 59 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87191760 |
| 60 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.86454004 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84485316 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.84411565 |
| 63 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84105060 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83830326 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82364368 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81959315 |
| 67 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81889063 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81887911 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80771613 |
| 70 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.79041382 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78750773 |
| 72 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78385307 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78151115 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.77355341 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77246524 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76692539 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.76665759 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76451441 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.76213551 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.75483612 |
| 81 | Melanogenesis_Homo sapiens_hsa04916 | 0.75444389 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75419877 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.75253067 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.75103359 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74447813 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74195401 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74010750 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.71717683 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71010686 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68101215 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67115082 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.66972965 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66887428 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.66543177 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66521026 |
| 96 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66023559 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65753832 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65679317 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64747873 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64562175 |
| 101 | Tight junction_Homo sapiens_hsa04530 | 0.63963610 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.63579418 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63533711 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63059451 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61970051 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61562379 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.60504478 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60230030 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.60070540 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59507921 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.59219018 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59171754 |
| 113 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58873216 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58580399 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58557066 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58156481 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57608582 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57178907 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.56884159 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56811262 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.56792748 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56257162 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56150863 |
| 124 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55827057 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55089250 |
| 126 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53212174 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53163239 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53151724 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51852448 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.51503501 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50001499 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49833774 |
| 133 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48865552 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48799942 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48707064 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.47197183 |
| 137 | Gap junction_Homo sapiens_hsa04540 | 0.46570962 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46208170 |
| 139 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45889867 |
| 140 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44992841 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44861804 |
| 142 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44772038 |
| 143 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44735644 |
| 144 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43187885 |
| 145 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42945580 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42655101 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39736577 |

